The Efficacy of Surgical Site Treatment With Ropivacaine in Laparoscopic Surgery

Western Galilee Hospital-Nahariya100 enrolled

Overview

Using local analgesia in laparoscopic surgery in order to reduce pain and to reduce the use of narcotic drugs.

At the end of laparoscopic surgery the investigators will spray ropivacaine in the surgical site; and later the investigators will monitor pain intensity and use of analgesic drugs

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

100

Conditions

Pain

Interventions

Topical useDRUG

Topical use of Ropivacaine in laparoscopic surgery

laparoscopic repair of inguinal herniaOTHER

intra-operative treatment with ropivacaine Vs placebo in laparoscopic repair of inguinal hernia

laparoscopic bariatric surgeryOTHER

intra-operative treatment with ropivacaine Vs placebo in laparoscopic bariatric surgery

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Laparoscopic bariatric surgery * Laparoscopic inguinal hernia surgery Exclusion Criteria: * Cardiac arrythmias * Active ischemic heart disease * pregnancy

Locations (1)

Naharia Medical Center

Nahariya, Israel

Outcomes

Primary Outcomes

Pain scale as measured by pain scale questionnaire

post operative pain intensity will be assisted by VAS(visual analog pain scale) scale at fixed times after surgery

Time frame: 1 Week

Secondary Outcomes

Reducing use of narcotics according to nurse records

patients will be treated by standard analgetic protocol, the records of analgetic drugs will be collected during patients hospitalization

Time frame: 1 Week

Central Contacts

Moaad H Farraj, Dr

CONTACT

0507887996 moaad.farraj@naharia.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.